• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by CorVel Corp.

    6/24/25 4:35:25 PM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email
    DEFA14A 1 d912651ddefa14a.htm DEFA14A DEFA14A
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 14A

    (Rule 14a-101)

    INFORMATION REQUIRED IN PROXY STATEMENT

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No. )

     

     

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material under §240.14a-12

    CORVEL CORPORATION

    (Name of Registrant as Specified in Its Charter)

    N/A

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     


    LOGO

     

    You invested in CORVEL CORPORATION and it’s time to vote!

    You have the right to vote on the proposals being presented at the 2025 Annual Meeting. This is an important notice regarding the availability of proxy materials for the 2025 Annual Meeting to be held on Thursday, August 7, 2025 at 8:30 a.m. Pacific Time.

    Get informed before you vote.

    View the Notice of Annual Meeting of Stockholders, Proxy Statement and 2025 Annual Report on Form 10-K at www.proxyvote.com OR you can receive a free paper or email copy of the materials by requesting them prior to Thursday, July 24, 2025. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit www.proxyvote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

     

    LOGO

    * Please check the meeting materials for any special requirements for meeting attendance. At the 2025 Annual Meeting, you will need to request a ballot to vote these shares.


    Vote at www.proxyvote.com

     

     

    THIS IS NOT A VOTABLE BALLOT.

    This is an overview of the proposals being presented at the

    upcoming 2025 Annual Meeting. Please follow the instructions

    on the reverse side to vote on these important matters.

     

     Proposals

           

    Board 

    Recommends 

     

     1.

      

    To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified;

      

     

    LOGO For All

      

     

    Nominees:

      
      

    01)  Michael G. Combs

      

    04)  Alan R. Hoops

      

    02)  Joanna C. Burkey

      

    05)  R. Judd Jessup

        

    03)  Steven J. Hamerslag

      

    06)  Jeffrey J. Michael

        
     

     2.

      

    To ratify the appointment of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026; and

      

    LOGO For

     

     3.

      

    To approve the 2025 Stock Incentive Plan.

      

    LOGO For

    Note: We may also consider and vote upon any other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

        

     

     

     

      

     

    Prefer to receive an email instead? While voting on www.proxyvote.com, be sure to click “Delivery Settings.”

    V76419-P35420

    Get the next $CRVL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Information Officer Shishin Maxim exercised 12,000 shares at a strike of $29.23 and sold $1,069,976 worth of shares (12,000 units at $89.16) (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    8/21/25 9:09:56 PM ET
    $CRVL
    Specialty Insurers
    Finance

    EVP - Risk Management Services Bertels Mark E. exercised 900 shares at a strike of $29.23 and sold $80,251 worth of shares (900 units at $89.17) (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    8/20/25 2:29:50 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Michael Jeffrey J

    4 - CORVEL CORP (0000874866) (Issuer)

    8/11/25 7:54:19 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    SEC Filings

    View All

    SEC Form 8-K filed by CorVel Corp.

    8-K - CORVEL CORP (0000874866) (Filer)

    8/12/25 6:48:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    8/7/25 4:30:49 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CORVEL CORP (0000874866) (Filer)

    8/4/25 7:30:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter and fiscal year ended March 31, 2025. Revenues for the quarter were $232 million, an increase from $207 million in the March quarter of 2024. Earnings per share for the quarter were $0.51, compared to $0.37 in the same quarter of the prior year.  Revenues for the fiscal year ended March 31, 2025 were $896 million, an increase from $795 million during the fiscal year ended March 31, 2024. Earnings per share for the fiscal year ended March 31, 2025 were $1.83, compared to $1.47 during the fiscal year ended March 31, 2024. The earnings per share numbers for the current an

    5/22/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product

    FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah's leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs of its partners. Throughout her 25 years with CorVel, Sarah has been instrumental in the company's success. In her previous role as Vice President of Network Solutions, Sarah playe

    2/13/25 7:25:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Retirement of V. Gordon Clemons

    FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company's Board of Directors (the "Board") and as Chairman of the Board, effective November 26, 2024, after 37 years of service. Clemons founded CorVel Corporation in 1988 and has served as Chairman of the Board since the Company went public in 1991. Effective upon Clemons' retirement, Michael G. Combs, the Company's President and Chief Executive Officer, was appointed as the new Chairman of the Board. Clemons has been an advisor to Combs since 2017, and he will continue to be available to Combs as an outside consultant. "Building CorVe

    11/29/24 1:30:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Appoints Jeff Gurtcheff Vice President of Enterprise Comp

    FORT WORTH, Texas , Feb. 02, 2022 (GLOBE NEWSWIRE) -- CorVel, a national provider of risk management solutions, has named Jeff Gurtcheff as Vice President of Enterprise Comp. With more than 30 years of experience, Gurtcheff brings a deep understanding of the industry with strategic leadership and management expertise. As Vice President of Enterprise Comp, Gurtcheff will refine product vision and strategy related to corporate goals and manage resources responsible for regulatory compliance, claims handling, quality, and standards and procedures. His position will also support product line profit growth by developing improved processes, risk management practices, and analytical reporting.

    2/2/22 7:08:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance